Reductive Methylation: An Alternative to Lysine → Arginine Mutagenesis
Journal of Peptide Science · 2026-07 · 32 (7)
DOI: 10.1002/psc.70110 ↗At a glance
Journal article in Journal of Peptide Science, published online on 2026-06-16. Written by Oscar J Molina and 4 co-authors. Institution: Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Major MEDLINE topics: Lysine, Arginine, Ribonuclease, Pancreatic. Cited 1 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Defense Science and Engineering Graduate Fellowship, Graduate Research Fellowship, NIGMS NIH HHS.
Abstract (original language)
Modification of lysine residues is a common strategy in protein engineering, whether to prevent posttranslational modifications, control bioconjugation, or improve crystallization. The standard genetic approach—replacement with arginine by site‐directed mutagenesis—preserves positive charge but alters other physicochemical attributes and cannot address the N‐terminal amino group. Here, we characterize reductive methylation as a chemical alternative. This reaction converts every primary amino group to a dimethylamino group rapidly under mild aqueous conditions. Using human ribonuclease 1 and a cytotoxic variant engineered to evade the endogenous ribonuclease inhibitor as model systems, we assess the effects of complete dimethylation on thermostability, enzymatic catalysis, protein–protein interaction, compatibility with bioconjugation, cellular uptake, and intracellular persistence. Dimethylation preserves thermostability and a protein–protein interaction. Enzymatic catalysis, in contrast, is reduced by 10 2 ‐ to 10 3 ‐fold, consistent with the role of catalytic lysine residues. Dimethylation is fully compatible with bioconjugation chemistry. Dimethylated and unmodified ribonucleases show comparable uptake and persistence in human cells. These findings establish reductive methylation as a practical and conservative strategy for lysine modification in protein and peptide engineering and support its use in applications such as biological proteolysis‐targeting chimeras (bioPROTACs).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
ORCID profiles: Oscar J Molina, Clair S Gutierrez, Jinyi Yang, Evans C Wralstad, Ronald T Raines
Funding
- National Defense Science and Engineering Graduate Fellowship
- Graduate Research Fellowship
- NIGMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
Cite
APA
Molina, O. J., Gutierrez, C. S., Yang, J., Wralstad, E. C., & Raines, R. T. (2026). Reductive Methylation: An Alternative to Lysine → Arginine Mutagenesis. Journal of Peptide Science, 32(7). https://doi.org/10.1002/psc.70110
Vancouver
Molina OJ, Gutierrez CS, Yang J, Wralstad EC, Raines RT. Reductive Methylation: An Alternative to Lysine → Arginine Mutagenesis. Journal of Peptide Science. 2026;32(7). doi:10.1002/psc.70110
BibTeX
@article{Molina2026,
author = {Molina, Oscar J and Gutierrez, Clair S and Yang, Jinyi and Wralstad, Evans C and Raines, Ronald T},
title = {Reductive Methylation: An Alternative to Lysine → Arginine Mutagenesis},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {7},
doi = {10.1002/psc.70110}
}
EUVIMED